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Development of IL-17-mediated
Delayed-Type Hypersensitivity Is Not
Affected by Down-Regulation of IL-25
Expression
Akina Ishii1, Keisuke Oboki1, Aya Nambu2, Hideaki Morita1,3, Tatsukuni Ohno1, Naoki Kajiwara1,2,
Ken Arae1,4, Hajime Sudo2, Ko Okumura2, Hirohisa Saito1,2 and Susumu Nakae1,2,5
ABSTRACT
Background: IL-25, which is a member of the IL-17 family, induces Th2 cell differentiation and Th2 cytokine
production, contributing to induction of Th2-type immune responses and diseases, as a result of which it sup-
presses Th1- and Th17-type immune responses.
Methods: To elucidate the role of IL-25 in the pathogenesis of IL-17-mediated delayed-type hypersensitivity
(DTH), IL-25-deficient mice were sensitized with methylated BSA (mBSA), and then a DTH reaction was in-
duced by mBSA challenge. mBSA-specific T-cell induction was assessed on the basis of cell proliferation and
cytokine production. The DTH reaction was evaluated on the basis of tissue swelling, histology and inflamma-
tory mediator expression.
Results: IL-25 expression was markedly reduced in local DTH lesions. However, mBSA-specific Th1, Th2 and
Th17 cell induction, and the mBSA-induced DTH reaction were comparable in IL-25-deficient and wild-type
mice.
Conclusions: IL-25 is not essential for differentiation of Th1, Th2 and Th17 cells in the sensitization phase or
induction of local inflammation in the elicitation phase of the mBSA-induced DTH reaction.
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INTRODUCTION
Delayed-type hypersensitivity (DTH) reactions,
which are classified as a type IV allergy, can be ex-
perimentally induced in rodents by immunization
with exogenous antigens such as pathogens (Myco-
bacterium, Leishmania and viruses), cells (allogenic
splenocytes and red blood cells from other species)
and protein antigens (methylated bovine serum albu-
min [mBSA], key hole limpet hemocyanin [KLH] and
ovalbumin [OVA]).1 During sensitization of rodents
with such antigens, antigen-specific memory T cells
develop in draining lymph nodes (LNs). After chal-
lenge of the sensitized rodents with the same anti-
gens, neutrophil-dominant inflammation is induced at
local sites dependent on activation of antigen-specific
memory T cells. Among the T cell subsets, CD4+
helper T cells (Th cells) are considered to be effec-
tors while CD8+ cytotoxic T cells (Tc cells) are nega-
tive regulators in the induction of DTH.1 Although it
is thought that IFN-γ-producing Th1 cells are impor-
tant for induction of DTH, the contribution of IFN-γ
differs depending on the antigen. Mice deficient in
IFN-γ or IFN-γR1 showed decreased immune re-
sponses during DTH induced by herpes simplex vi-
rus type-12,3 but not Mycobacterium tuberculosis.4 In
addition, IFN-γ-deficient (IFN-γ--) mice showed at-
tenuated DTH responses to KLH,5,6 but aggravated
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responses to OVA and mBSA.7,8 On the other hand,
we previously demonstrated that IL-17-- mice showed
the reduced DTH reaction induced by mBSA and My-
cobacterium tuberculosis.9,10 Therefore, in certain
cases, Th17 cells rather than Th1 cells seem to be
crucial for the development of DTH.
IL-25 (also called IL-17E), which is a member of
the IL-17 family of cytokines, can enhance Th2 cell
differentiation11 and Th2 cytokine production,12 con-
tributing to the induction of Th2 cytokinecell-
mediated immune responses such as to nematode in-
fection13,14 and diseases such as allergic asthma.15,16
Conversely, IL-25-mediated Th2 cytokines suppress
Th1-type immune responses. IL-25 is also known to
suppress Th17 cell differentiation and Th17 cell-
mediated autoimmune disorders.17 These observa-
tions suggest that IL-25 may influence the pathogene-
sis of Th1 andor Th17 cytokinecell-mediated type
IV allergies such as DTH. However, the role of IL-25
in these responses is poorly understood. In the pre-
sent study, we investigated the role of IL-25 in Th17
cytokinecell-mediated DTH induced by mBSA in IL-
25-- mice.
METHODS
MICE
Chimeric mice were generated from il25-targeted 129
ES cells, which were deleted exon 1 containing an in-
itial codon and exon 2 of il25 genes, by Lexicon Phar-
maceuticals (The Woodlands, TX, USA). Male age-
matched BALBcA-IL-25-- mice (N8) and -wild-type
mice (Sankyo Lab, Tsukuba, Japan) were used. The
mice were housed under specific pathogen-free con-
ditions at the National Research Institute for Child
Health and Development, and the animal protocols
were approved by the Institutional Review Board of
the National Research Institute for Child Health and
Development.
mBSA-INDUCED DTH
mBSA-induced DTH was established as described
elsewhere.9,18,19 In brief, after shaving the dorsal hair
at the base of the tail with clippers, mice were sensi-
tized with 200 μl of 1.25 mgml mBSA (Sigma-
Aldrich, MO, USA) emulsified in complete Freund’s
adjuvant (CFA; Difco Laboratories, MI, USA) by sub-
cutaneous injection to the shaved site. Six days later,
the mice were challenged by intradermal injection of
20 μl of 10 mgml mBSA in PBS into one footpad and
20 μl of PBS alone into another footpad as a control.
For a secondary DTH reaction, mice were re-
challenged as described above 6 days after the first
challenge. The footpad thickness was measured be-
fore (0 hours or 0 days) and after mBSA or PBS chal-
lenge using an engineer’s calipers (Ozaki, Tokyo, Ja-
pan) by an investigator who was blinded to the
mouse genotypes. The data were calculated as fol-
lows: increase in footpad thickness (mm) = (footpad
thickness after challenge) - (footpad thickness before
challenge).
LN CELL CULTURE
Mice were subcutaneously sensitized with 200 μl of
1.25 mgml mBSA emulsified in CFA as described
above. Six days later, inguinal LNs were collected,
and the LN cells (4 × 105 cellswell of 96-well flat-
bottom plates) were cultured in the presence and ab-
sence of 40 μgml mBSA at 37℃ for 72 hours. The
mBSA-specific LN cell proliferative responses were
determined by pulsing with 0.25 μCi [3H]-labeled
thymidine for 6 hours. For flow cytometry, LN cells
(5 × 106 cellswell of 24-well plates) were cultured in
the presence and absence of 40 μgml mBSA at 37℃
for 72 hours and then stimulated with 1 μgml iono-
mycin (Sigma-Aldrich) and 0.1 μgml PMA in the
presence of 1 μM monensin (Sigma-Aldrich) for 4
hours. After washing, the cells were incubated on ice
with anti-CD16CD32 mAb (2.4G2; BD Biosciences,
CA, USA) in FACS buffer (Hanks’ buffer containing
2% FCS) for FcR blocking for 15 min and then with
APC-conjugated anti-mouse CD4 mAb (GK1.5; eBi-
osciences, CA, USA) for 30 min. After washing, the
cells were treated with Fix Buffer I (BD Biosciences)
at room temperature for 15 min. Then the cells were
washed with 0.1% saponin (Sigma-Aldrich) in FACS
buffer and incubated with FITC anti-mouse Foxp3
mAb (FJK-16s; eBiosciences) and PE anti-mouse IL-
17 mAb (TC11-18H10; BD Biosciences) or FITC anti-
mouse IFN-γ mAb (XMG1.2; eBiosciences) and PE
anti-mouse IL-4 mAb (11B11; BD Biosciences) at 4℃
for 30 min. IL-17 and Foxp3 expressions as well as
IFN-γ and IL-4 expressions in CD4+ T cells were ana-
lyzed on a FACSCalibur (BD Biosciences) using
CellQuest (BD Biosciences) or FlowJo (Tree Star,
OR, USA) software.
CYTOKINE ELISA
Cytokine levels in the culture supernatants of mBSA-
specific LN cells were determined with mouse IFN-γ,
IL-4, IL-17 and IL-17EIL-25 ELISA kits obtained from
BD Biosciences, eBiosciences or R&D systems.
QUANTITATIVE PCR
Twenty-four hours after mBSA or PBS challenge, the
footpads were harvested and homogenized. Total
RNA in the homogenates was isolated using ISOGEN
(NIPPON GENE, Tokyo, Japan) and RNeasy Mini Kit
(QIAGEN, Hilden, Germany). Using the isolated
RNA, cDNA was obtained by RT-PCR with an iScript
cDNA Synthesis Kit (Bio-Rad, CA, USA). Quantitative
real-time PCR was performed with THUNDERBIRD
SYBR qPCR Mix (TOYOBO, Osaka, Japan) and an
Applied Biosystems 7300 real-time PCR system (Ap-
plied Biosystems, CA, USA). The relative gene ex-
pression was determined against GAPDH gene ex-
pression. PCR primers were designed as shown in
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Reverse (5’ -3’ )Forward (5’ -3’ )Gene
AGGTCCACCACCCTGTTGCTCCCACTCTTCCACCTTCGATGGAPDH
TGTGGGTTGTTGACCTCAAACGAACTGGCAAAAGGATGGTGAIFN-γ
GATCCACACTCTCCAGCTGCACAACCAACAAGTGATATTCTCCATGIL-1β
CAGCTTATCGATGAATCCAGGCTCCAAGGTGCTTCGCATATTTTIL-4
ATGTGATCCTCCTGCGTCCATCCCTCATCCTCTTCGTTGCATIL-5
AAGTGCATCATCGTTGTTCATACAGAGGATACCACTCCCAACAGACCIL-6
GGCATAGGCAGCAAACCATGGGCAGCAGCTTGAGCACATTIL-13
AGAATTCATGTGGTGGTCCAGCCCGCAATGAAGACCCTGATAGATIL-17
ACACCAGTGGCAACCTTCATGTTGCACAGCAGTCTTGAACCTCIL-21
GGTGGAGAAAGTGCCTGTGCGGCATTTCTACTCAGGAACGGAIL-25
TCTCCTCCACTAGAGCCAGCTGCAGGCCTTCTTCGTCCTTCACIL-33
CACTTGGTGGTTTGCTACGAGCCTCCCTCTCATCAGTTCTTNF
TGTGCCATTTCCTGAGTACCGTCAATCCTATCCCTGGCTGCCTSLP
TGAACGTCTCTGTCCCGAGCCACGTGTTGACGCTTCCCTTKC
ACTCTCAGACAGCGAGGCACATAACTGACCTGGAAAGGAGGAGCMIP-2
Table 1 Primer design
Fig. 1 Normal antigen-specific LN cel responses in IL-25-/- mice. BALB/c-wild-type (open columns, 
n = 6) and -IL-25-/- (closed columns. n = 6) mice were immunized subcutaneously with mBSA emulsi-
fied in CFA. Six days later, inguinal LNs were colected, and LN cels were cultured in the presence 
and absence of 40 μg/ml mBSA for 72 hours. Proliferative responses were determined by [3H]-TdR 
incorporation. The levels of IL-4, IFN-γ and IL-17 in the culture supernatants were measured by 
ELISA. Data show the mean + SE. *p < 0.05 vs. medium alone.
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Table 1.
HISTOLOGY
Twenty-four hours after mBSA or PBS challenge, the
footpads were harvested and fixed in 4% paraformal-
dehyde, decalcified in Morse’s solution (10% sodium
citrate and 22.5% formic acid) and embedded in paraf-
fin. Sections were prepared and stained with hemato-
xylin-eosin.
DETECTION OF mBSA-SPECIFIC IgGs
Sera were collected 6 days after challenge for meas-
urement of mBSA-specific IgG levels. ELISA plates
(Nunc, 442404) were coated overnight with 10 μgml
mBSA in PBS at 4℃. After blocking with PBS con-
taining 10% FCS, optimally diluted serum samples
were applied, and the plates were incubated at room
temperature for 1 hour. After washing, biotinylated
Ishii A et al.
402 Allergology International Vol 59, No4, 2010 www.jsaweb.jp
Fig. 2 Normal antigen-specific Th subset diferentiation in IL-25-/- mice. LN cels cultured as described for Fig-
ure 1 were further stimulated with PMA plus ionomycin in the presence of monensin for 4 hours. Then the profiles 
of intracelular cytokine (IFN-γ, IL-4 and IL-17) and transcription factor (Foxp3) expression were determined by 
flow cytometry. (A) Representative flow cytometry data. (B) The mean + SE (n = 6) in (A). *p < 0.05 vs. medium 
alone.
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anti-mouse IgG1 (A85-1; BD Biosciences), IgG2a
(R19-15; BD Biosciences), IgG2b (R12-3; BD Bi-
osciences) or IgG3 (R40-82; BD Biosciences) mAb
was added, followed by incubation at room tempera-
ture for 1 hour. Then, after washing, HRP-conjugated
streptavidin (BD Biosciences) was added, followed
by incubation at room temperature for 30 minutes.
TMB substrate (KPL, MD, USA) was used as the
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Fig. 3 Decreased local IL-25 expression during mBSA-induced DTH. 
BALB/c-wild-type mice were immunized subcutaneously with mBSA emulsi-
fied in CFA. Six days later, the mice were chalenged by injection of mBSA 
into one footpad and PBS alone into another footpad. Twenty-four hours af-
ter chalenge, mRNA was extracted from the mBSA- and PBS-injected 
footpads. The expressions of IL-6, IL-17, IL-21, IL-25, IL-33 and TSLP were 
determined by quantitative PCR. Data show the mean + SE (n = 5). *p < 
0.05 vs. PBS-injected footpads.
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substrate for enzymatic reaction. The reaction was
stopped by addition of 1N HCl, and then the absor-
bance was measured using a plate reader at 450 nm.
Data show the absorbance value at 450 nm.
STATISTICAL ANALYSES
Data show the mean with SD (for measurement of
footpad swelling) or SE (for other experiments) and
were evaluated for statistical significance using the
two-tailed Student’s t test.
RESULTS
IL-25 IS NOT REQUIRED FOR Th CELL DIFFER-
ENTIATION AFTER mBSA SENSITIZATION
It has been shown that IL-25 can enhance Th2 cell dif-
ferentiation11 but conversely suppresses Th1 cell and
Th17 cell differentiationactivation.13,17 These obser-
vations suggest that IL-25 may influence the differen-
tiation andor activation of Th cell subsets during IL-
17-mediated, mBSA-induced DTH. To elucidate this,
LN cells from mBSA-sensitized IL-25-- and wild-type
mice were cultured in the presence and absence of
mBSA in vitro. The mBSA-specific proliferative re-
sponses of LN cells from IL-25-- mice were compara-
ble to those from wild-type mice (Fig. 1). Moreover,
the levels of IFN-γ and IL-17, but not IL-4, in the cul-
ture supernatants were similarly increased in both
mouse strains after stimulation with mBSA (Fig. 1).
The levels of IL-25 in the setting were below the limit
of detection of ELISA (data not shown). Consistent
with this, the proportions of IFN-γ+ and IL-17+ CD4+ T
cells were also equivalent in mBSA-stimulated LN
cells from IL-25-- and wild-type mice(Fig. 2A, B). The
proportion of IL-4-producing cells was not increased
in LN cell cultures from both strains after mBSA
stimulation, while that of Foxp3-expressing cells was
significantly increased(Fig. 2A, B). However, the in-
tensity of Foxp3 expression in that setting was rela-
tively low compared with in CD4+CD25+ cells that
were freshly harvested from mouse spleen (data not
shown). Thus, these observations indicate that IL-25
is not required for differentiation and activation of
Th1 and Th17 cells after sensitization with mBSA.
IL-25 IS NOT ESSENTIAL FOR INDUCTION OF
LOCAL INFLAMMATION DURING mBSA-
INDUCED DTH
Although IL-25 is dispensable for induction of mBSA-
specific Th cells in the sensitization phase of DTH
(Fig. 1, 2), IL-25 may be involved in the elicitation of
local inflammation in DTH by affecting Th cell activa-
tion. Therefore, we examined the expressions of
Th17 cell-related and Th2 cytokine-inducible cytoki-
nes in local inflammatory lesions of wild-type mice
during mBSA-induced DTH. The mRNA expressions
of IL-17 and IL-6 (a crucial cytokine for Th17 cell dif-
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Fig. 4 Normal DTH reaction in IL-25-/- mice. BALB/c-wild-
type (squares, n = 21) and -IL-25-/- (circles, n = 20) mice 
were immunized subcutaneously with mBSA emulsified in 
CFA. Six days later, the mice were chalenged by injection 
of mBSA into one footpad (closed symbols) and PBS alone 
into another footpad (open symbols). Before (indicated as 
“0 h”) and after chalenge, the thickness of each footpad 
was measured with an engineer’ scalipers. Data show the 
mean ± SD. *p < 0.05 vs. PBS-injected footpads.
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Fig. 5 Histological analysis of local lesions of IL-25-/- mice during DTH. Twenty-four 
hours after chalenge as in Figure 4, mBSA- and PBS-injected footpads from BALB/c-wild-
type and -IL-25-/- mice were harvested, and sections were stained with hematoxylin and 
eosin. The data show representative results from each mouse strain. Scale bar = 100 μm.
Wild-type IL-25-/-
PBS
mBSA
ferentiation20) were markedly increased in the mBSA-
challenged footpads compared with the PBS-injected
footpads (Fig. 3). Like IL-6, IL-21 is known to be in-
volved in Th17 cell differentiation,21-23 and it is also
important for follicular Th cell development24,25 and
Th2 cell-mediated immune responses.26 In the above
setting, the expression of IL-21 mRNA was below the
limit of detection of our quantitative PCR system (Fig.
3). Similar to IL-25, TSLP and IL-33 are known to in-
duce Th2 cytokine production by Th2 cells.27 The ex-
pression of IL-33 mRNA was increased in the mBSA-
challenged footpads compared with the PBS-injected
footpads (Fig. 3). On the other hand, interestingly,
mRNA expression for IL-25 and TSLP was signifi-
cantly decreased after the challenge with mBSA (Fig.
3). These observations suggest that IL-25 may play a
role in the induction of DTH. However, as shown in
Figure 4, the development of DTH in IL-25-- mice
was comparable to that in wild-type mice after mBSA
challenge (Fig. 4). Consistent with this, local inflam-
matory cell infiltration determined by histological
analysis was also similarly observed in wild-type mice
and IL-25-- mice (Fig. 5). In wild-type mice during the
DTH reaction, mRNA expression of both Th1 (IFN-γ)
and Th2 (IL-4, IL-5 and IL-13) cytokines was signifi-
cantly increased in the mBSA-injected footpads com-
pared with the PBS-injected footpads (Fig. 6). Al-
though IL-25 is well-known to induce Th2 cytokine
production,12 IL-25-deficiency did not have any effect
on mRNA expression levels and patterns for the Th1
Role in IL-25 in DTH
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Fig. 6 Normal local expression of proinflammatory mediators in IL-25-/- 
mice during DTH. Twenty-four hours after chalenge as in Figure 4, mRNA 
was isolated from mBSA- and PBS-injected footpads of BALB/c-wild-type 
and -IL-25-/- mice. The expressions of cytokines and chemokines were de-
termined by quantitative PCR. Data show the mean + SE (n = 5). *p < 0.05 
vs. PBS-injected footpads, and **p < 0.05 vs. wild-type mice.
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or Th2 cytokines and TSLP and IL-33 in the local
sites during mBSA-induced DTH (Fig. 6). Like TNF
and IL-1, IL-17, a Th17 cytokine, is known to be cru-
cial for infiltration of neutrophils, which are a major
infiltrating leukocyte population in local inflammatory
lesions of DTH. Expression of these proinflammatory
cytokines and neutrophil chemoattractant factors
such as KC and MIP-2 was also comparably in-
creased in both wild-type and IL-25-- mice after
mBSA challenge (Fig. 6). These observations clearly
indicate that IL-25 is dispensable for the elicitation of
local inflammation during DTH induced by mBSA.
IL-25 IS NOT NECESSARY FOR THE DEVELOP-
MENT OF SECONDARY DTH REACTIONS
One week after mBSA challenge, we collected sera
from wild-type and IL-25-- mice and determined the
levels of mBSA-specific IgGs by ELISA. The levels of
mBSA-specific IgG1 and IgG3 as well as that of
mBSA-specific IgG2a were partially, but not signifi-
cantly, decreased or increased in sera from the IL-
25-- mice in comparison with the wild-type mice (Fig.
7). These observations suggest that IL-25 may con-
tribute to the induction of secondary DTH, and mice
were re-challenged with mBSA 6 days after the first
mBSA injection to investigate this. However, the de-
gree of footpad swelling was identical between wild-
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Fig. 7 No significant efect of IL-25-deficiency on antigen-
specific Ig production during DTH. Six days after chalenge 
as in Figure 4, sera were colected from BALB/c-wild-type 
(open columns, n = 9) and -IL-25-/- (closed columns, n = 10) 
mice. The levels of mBSA-specific IgG1, IgG2a, IgG2b and 
IgG3 were determined by ELISA. The data show the mean + 
SE.
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Fig. 8 Normal secondary DTH reaction in IL-25-/- mice. 
BALB/c-wild-type (squares, n = 10) and -IL-25-/- (circles, n = 
14) mice were immunized subcutaneously with mBSA emul-
sified in CFA. Six days later, the mice were chalenged by in-
jection of mBSA into one footpad (closed symbols) and PBS 
alone into another footpad (open symbols). Six days after 
the first chalenge, mice were re-chalenged by injection of 
mBSA or PBS into the respective footpads. Before (indi-
cated as “0 days”) and after chalenge, the thickness of 
each footpad was measured with an engineer’ scalipers. 
Data show the mean + or - SD. *p < 0.05 vs. PBS-injected 
footpads.
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type and IL-25-- mice in the experimental setting
(Fig. 8). Taken all together, our results indicate that
IL-25 is not a major mediator in the induction of Th17
cell-mediated DTH reactions.
DISCUSSION
Expression of IL-25 mRNA has been constitutively de-
tected in various mouse tissues such as the colon and
lung.12 In immune cells, IL-25 mRNA andor proteins
were detected in CD4+ and CD8+ T cells in the cecal
patch (but not in peripheral LNs),13 in vitro-skewed
Th2 cells,12 bone marrow-derived mast cells,28 alveo-
lar macrophages,29 eosinophils and basophils.30 Both
administration of recombinant IL-25 and infection by
adenovirus carrying IL-25 cDNA in mice result in ele-
vation of Th2 cytokine (IL-4, IL-5 and IL-13) expres-
sion and serum IgA, IgE and IgG1 levels, and in-
crease eosinophils in the blood and tissues.12 IL-25 in-
duces Th2 cytokine production by myeloid cells12,31
and differentiation of Th2 cells from naïve T cells de-
pendent on IL-4 and STAT-6.11 Therefore, IL-25 is sur-
mised to suppress Th1 cell differentiation and Th1
cell-mediated immune responses by enhancing Th2
cell differentiation and activation. In addition, IL-4 can
inhibit Th17 cell differentiation,32 suggesting that IL-
25-induced Th2 cytokines are involved in the regula-
tion of Th17 cytokine-mediated immune responses.
In support of this, IL-25-- mice showed reduced Th2-
type immune responses but increased Th1 cell and
Th17 cell activation.13,17 In particular, IL-13 induced
by IL-25 inhibited dendritic cell expression of mRNA
for IL-1, IL-6 and IL-23, which are required for Th17
cell differentiation.17 These observations suggest that
IL-25 is a key mediator for Th2-type immune re-
sponses and an important regulatory cytokine for in-
duction of Th1- andor Th17-type immune responses.
It was shown that development of DTH induced by
mBSA was attenuated in IL-17-- mice9 but exacer-
bated in IFN-γ-- mice,8 suggesting that IL-17 is a
proinflammatory cytokine for the event and that
IFN-γ is an anti-inflammatory cytokine. As noted
above, since IL-25 can regulate both Th1- and Th17-
type immune responses, it could be readily expected
that IL-25 would influence the pathogenesis of mBSA-
induced DTH. However, we found that mBSA-specific
Th1, Th2 and Th17 cell differentiation and activation
were similarly observed between IL-25-- and wild-
type mice after sensitization with mBSA, since IL-25
was barely detectable in the setting(Fig. 1, 2). These
observations indicate that IL-25 is not essential for in-
duction of antigen-specific memory T cells in the sen-
sitization phase of DTH induced by mBSA.
As expected, we found that expression of both
Th17-related cytokines (IL-17, IL-6 and IL-1β) and Th
1 cytokine (IFN-γ) was profoundly increased in the in-
flamed lesion during mBSA-induced DTH(Fig. 3, 6).
Interestingly, the expression of such Th2 cytokines
as IL-4, IL-5 and IL-13 was also up-regulated in the
setting, although expression of both IL-25 and TSLP
was decreased (Fig. 3). Therefore, it seemed that
down-regulation of IL-25 expression in the local le-
sion may contribute to induction of local inflamma-
tion during mBSA-induced DTH. However, we
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showed here that comparable tissue swelling was ob-
served in both IL-25-- and wild-type mice during
mBSA-induced DTH (Fig. 4). Consistent with this, in-
flammation as assessed by histology and the expres-
sion of proinflammatory cytokines and chemokines in
the local lesion were also identical in these mouse
strains after mBSA challenge(Fig. 5, 6). The produc-
tion of serum mBSA-specific IgG1, IgG2a and IgG3
was partly, but not significantly, influenced by IL-25-
deficiency (Fig. 7), but those changes did not affect
induction of DTH by mBSA (Fig. 8). Therefore, our
observations indicate that IL-25 is not responsible for
the induction of local inflammation in the elicitation
phase of DTH induced by mBSA, although IL-25 ex-
pression was down-regulated in the setting.
In summary, IL-25 is not essential for differentia-
tion of Th1, Th2 and Th17 cells in the sensitization
phase or induction of local inflammation in the elicita-
tion phase of mBSA-induced DTH.
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